Leadership Overview
Haemonetics has 6 executives leading key functions including finance, operations, legal, and regional leadership.
Driven by a commitment to improving patient care, Haemonetics provides innovative medical products and solutions across critical markets like blood collection and hospital transfusion services, aiming to reduce healthcare costs globally.
Driven by a commitment to improving patient care, Haemonetics provides innovative medical products and solutions across critical markets like blood collection and hospital transfusion services, aiming to reduce healthcare costs globally.
Leadership Roles at Haemonetics
James D'Arecca - Chief Financial Officer
James D'Arecca, the Chief Financial Officer at Haemonetics, directs the company's financial strategy and operations. Overseeing all fiscal activities, D'Arecca ensures robust financial planning, accurate reporting, and effective capital allocation to support Haemonetics' global growth initiatives. This leadership role involves managing investor relations, optimizing financial performance, and maintaining strong relationships with financial institutions. By driving financial discipline, James D'Arecca directly contributes to the company's objective of reducing healthcare costs through its innovative medical products. The Chief Financial Officer's oversight extends to budgeting, forecasting, and risk management, safeguarding the company's assets and ensuring long-term financial stability. D'Arecca's strategic financial guidance underpins Haemonetics' mission to improve patient care worldwide.
Marcia Silvestro - Group Chief Financial Officer
Marcia Silvestro, the Group Chief Financial Officer at Haemonetics, manages the financial health and strategic fiscal direction for specific business units. Silvestro's responsibilities include overseeing financial planning, analysis, and reporting for key operational segments, ensuring alignment with the company's overall financial objectives. This role involves close collaboration with divisional leaders to drive profitability and manage financial risks. By providing targeted financial insights, Marcia Silvestro supports the effective deployment of resources for Haemonetics' innovative medical products. The Group Chief Financial Officer's expertise is crucial in navigating complex financial landscapes and optimizing financial performance across different market segments. Silvestro's leadership reinforces Haemonetics' dedication to reducing healthcare costs and improving patient outcomes.
Frankie Chan - Executive Vice President & Chief Operating Officer
Frankie Chan, the Executive Vice President & Chief Operating Officer at Haemonetics, orchestrates the company's global operational execution. Overseeing day-to-day business activities, Chan drives efficiency and effectiveness across all functional areas, ensuring seamless delivery of Haemonetics' medical products and solutions. This critical role involves managing supply chain logistics, manufacturing processes, and operational scaling to meet market demands. By optimizing operational workflows, Frankie Chan directly supports the company's commitment to improving patient care and reducing healthcare costs. The Chief Operating Officer's strategic focus ensures that Haemonetics' technology addresses key medical markets, including blood component collection and hospital transfusion services. Chan's leadership ensures operational excellence, reinforcing the company's legacy of innovation and customer support.
Keiko Hattori - President, Haemonetics (Japan)
Keiko Hattori, the President, Haemonetics (Japan), leads the company's strategic initiatives and operational execution within the Japanese market. Hattori oversees all business functions in Japan, driving growth and ensuring the successful delivery of Haemonetics' innovative medical products and solutions to local customers. This leadership role involves developing market-specific strategies, managing regional sales and operations, and fostering strong customer relationships. By tailoring Haemonetics' offerings to the Japanese healthcare landscape, Keiko Hattori directly contributes to improving patient care and reducing healthcare costs in the region. The President's focus on local market dynamics ensures alignment with the company's global mission. Hattori's leadership strengthens Haemonetics' presence and impact in Japan, upholding the company's commitment to quality and integrity.
Gregory Olen - Vice President, Chief Information Officer
Gregory Olen, the Vice President, Chief Information Officer at Haemonetics, directs the company's information technology strategy and infrastructure. Olen oversees the development and implementation of robust IT systems that support Haemonetics' global operations, ensuring data security, system reliability, and technological innovation. This leadership position involves managing all aspects of the IT department, including cybersecurity, enterprise resource planning, and digital transformation initiatives. By leveraging technology, Gregory Olen enhances operational efficiency and supports the company's mission to improve patient care. The Chief Information Officer's strategic vision ensures that Haemonetics maintains a competitive edge through advanced technological solutions. Olen's expertise is vital for integrating IT effectively with business objectives, driving the company's commitment to quality and integrity.
Sandra Jesse - Executive VP & Chief Legal Officer
Sandra Jesse, the Executive VP & Chief Legal Officer at Haemonetics, provides comprehensive legal counsel and oversees all legal affairs for the organization. Jesse directs the company's legal strategy, ensuring compliance with all applicable laws and regulations across its global operations. This pivotal role involves managing corporate governance, intellectual property, litigation, and regulatory matters related to Haemonetics' medical products and solutions. By safeguarding the company's legal interests, Sandra Jesse supports its commitment to integrity and quality. The Chief Legal Officer's expertise is essential in navigating the complex legal and regulatory environments of the healthcare industry. Jesse's leadership ensures that Haemonetics operates ethically and responsibly, reinforcing its dedication to improving patient care and reducing healthcare costs worldwide.
Explore Leadership Teams in Manufacturing
Benco Dental, headquartered in Pittston, Pennsylvania, is a family-owned full-service dental supply distributing company.
Company Leadership BF
MD
AS
KC
Founded in 1968, Novanta together with its subsidiaries, designs, manufactures, markets, and sells photonics, vision, and precision motion components and sub-systems to original equipment manufacturers in the medical and industrial markets worldwide. The company sells its products through its direct sales force, resellers, distributors, and system integrators under the Cambridge Technology, Lincoln Laser, Synrad, Laser Quantum, ARGES, WOM, NDS, NDSsi, Med X Change. Novanta is a trusted technology partner to medical and advanced industrial OEMs (original equipment manufacturers), with deep proprietary expertise in photonics, vision and precision motion technologies. We engineer mission-critical core components and subsystems that deliver extreme precision and performance, enabling our customers to improve productivity, achieve breakthrough performance and enhance peoples lives. The company is headquartered in Bedford, Massachusetts.
Company Leadership LC
JL
ROMTech® is thrilled to present our patented and groundbreaking rehabilitation technology, designed to serve a variety of orthopedic indications. Our revolutionary technology is improving patient outcomes, cutting cost of care, and overhauling the way postoperative orthopedic care is delivered.
Company Leadership GE
PL
MR
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.
Company Leadership
Frequently Asked Questions Regarding Haemonetics Top Executives and Leadership Team
